SAMSARA BIOCAPITAL, LLC
CIK
1744967
Location
PALO ALTO, CA
Portfolio Value
Mid
$1,217,460,852
Diversification
Moderately concentrated
Filing Date
Global Rank
#1,753
/ 8,700
▲ 486
Top Industry
Biotechnology
93.6%
Period ended 2 months ago
Filed Aug 14, 2026 · 29d
26 quarters · since Mar 2020
Portfolio Concentration
24 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
31.2%
−2.0 pts
Top 5
73.0%
−4.1 pts
Top 10
90.5%
−2.1 pts
HHI
1,534
Moderately concentrated−166
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,217,460,852 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced
5 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | −436,979 | 1,395,587 | $6,517,391 | |
| UPB | Upstream Bio, Inc. | −382,330 | 353,717 | $2,447,721 | |
| JBIO | Jade Biosciences, Inc. | −232,561 | 736,237 | $16,359,186 | |
| KLRS | Kalaris Therapeutics, Inc. | −66,906 | 12,881,175 | $52,426,382 | |
| ABVX | Abivax S.A. | −1,486 | 55,095 | $7,341,959 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
4 positions
Sold Out
Positions the filer fully exited
2 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PVLA | Palvella Therapeutics, Inc. | 38,432 | $4,790,548 | |
| — | 60,873 | $0 | ||
| No positions match the current search. | ||||
24 tracked positions ·
$1,217,460,852 total
· filing declares
24 positions · $1,217,462,122
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Held | 6,897,652 | $379,370,860 | 31.16% | |
| ALMS |
Alumis Inc.
Healthcare
|
Held | 6,345,219 | $178,554,462 | 14.67% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Held | 5,871,018 | $158,400,065 | 13.01% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Held | 3,149,128 | $105,464,296 | 8.66% | |
| ALMR |
Alamar Biosciences, Inc.
Healthcare
|
NEW | 2,480,310 | $67,191,597 | 5.52% | |
| NGNE |
Neurogene Inc.
Healthcare
|
Held | 1,717,127 | $54,003,644 | 4.44% | |
| KLRS |
Kalaris Therapeutics, Inc.
Healthcare
|
Reduced | 12,881,175 | $52,426,382 | 4.31% | |
| SGP |
SpyGlass Pharma, Inc.
Healthcare
|
Held | 2,109,953 | $46,967,553 | 3.86% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Held | 1,062,872 | $35,287,350 | 2.90% | |
| IVA |
Inventiva S.A.
Healthcare
|
Added | 6,314,805 | $23,869,962 | 1.96% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Reduced | 736,237 | $16,359,186 | 1.34% | |
| PBLS |
Parabilis Medicines, Inc.
Healthcare
|
NEW | 556,044 | $15,218,924 | 1.25% | |
| VTVT |
vTv Therapeutics Inc.
Healthcare
|
Held | 298,496 | $11,238,374 | 0.92% | |
| AQST |
Aquestive Therapeutics, Inc.
Healthcare
|
Held | 2,500,000 | $10,400,000 | 0.85% | |
| NKTX |
Nkarta, Inc.
Healthcare
|
Held | 3,507,666 | $9,926,694 | 0.82% | |
| ARTV |
Artiva Biotherapeutics, Inc.
Healthcare
|
NEW | 954,861 | $9,262,151 | 0.76% | |
| RANI |
Rani Therapeutics Holdings, Inc.
Healthcare
|
Added | 10,369,159 | $7,880,560 | 0.65% | |
| AGMB |
Agomab Therapeutics NV
Healthcare
|
Held | 600,000 | $7,788,000 | 0.64% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 55,095 | $7,341,959 | 0.60% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Reduced | 1,395,587 | $6,517,391 | 0.54% | |
| ELOX |
Eloxx Pharmaceuticals, Inc.
Healthcare
|
NEW | 400,000 | $5,552,000 | 0.46% | |
| CHRS |
Coherus Oncology, Inc.
Healthcare
|
Held | 3,428,571 | $4,799,999 | 0.39% | |
| UPB |
Upstream Bio, Inc.
Healthcare
|
Reduced | 353,717 | $2,447,721 | 0.20% | |
| GOSS |
Gossamer Bio, Inc.
Healthcare
|
Held | 7,222,559 | $1,191,722 | 0.10% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.